statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	455
SG - Singapore	148
DE - Germania	67
CN - Cina	62
GB - Regno Unito	42
SE - Svezia	41
BR - Brasile	36
FR - Francia	34
IT - Italia	32
VN - Vietnam	27
IN - India	21
UA - Ucraina	16
IE - Irlanda	15
ID - Indonesia	11
FI - Finlandia	10
RU - Federazione Russa	10
CA - Canada	8
BE - Belgio	6
PK - Pakistan	5
CZ - Repubblica Ceca	4
HK - Hong Kong	4
MX - Messico	4
NL - Olanda	4
IQ - Iraq	3
IR - Iran	3
JP - Giappone	3
KR - Corea	3
TR - Turchia	3
AR - Argentina	2
AU - Australia	2
BD - Bangladesh	2
CO - Colombia	2
ES - Italia	2
ET - Etiopia	2
LT - Lituania	2
PL - Polonia	2
SA - Arabia Saudita	2
UY - Uruguay	2
VE - Venezuela	2
AE - Emirati Arabi Uniti	1
AT - Austria	1
AZ - Azerbaigian	1
BZ - Belize	1
CH - Svizzera	1
CL - Cile	1
DO - Repubblica Dominicana	1
EC - Ecuador	1
EE - Estonia	1
GD - Grenada	1
HN - Honduras	1
IL - Israele	1
JO - Giordania	1
KG - Kirghizistan	1
KW - Kuwait	1
KZ - Kazakistan	1
LA - Repubblica Popolare Democratica del Laos	1
LB - Libano	1
LV - Lettonia	1
MA - Marocco	1
NG - Nigeria	1
PE - Perù	1
PH - Filippine	1
PT - Portogallo	1
TH - Thailandia	1
TT - Trinidad e Tobago	1
TW - Taiwan	1
TZ - Tanzania	1
Totale	1.127

Nome	#
Is there a dose-response relationship of metformin treatment in patients with polycystic ovary syndrome? Results from a multicentric study.	175
Metformin versus myoinositol: which is better in obese PCOS patients? A randomized controlled crossover study.	159
Metformin versus myoinositol: which is better in obese PCOS patients? A randomized controlled crossover study	154
The link between metabolic features and TSH levels in polycystic ovary syndrome is modulated by the body weight: an euglycaemic-hyperinsulinaemic clamp study.	150
Expectant management may reduce overtreatment in women affected by unexplained infertility confirmed by diagnostic laparoscopy.	139
Using a 16-French resectoscope as an alternative device in the treatment of uterine lesions: a randomized controlled trial	129
Expectant management may reduce overtreatment in women affected by unexplained infertility confirmed by diagnostic laparoscopy.	116
The Role of Anti-Müllerian Hormone in the Characterization of the Different Polycystic Ovary Syndrome Phenotypes	115
Totale	1.137

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	11	0	0	0	0	0	0	0	0	0	0	10	1
2021/2022	81	5	7	2	2	2	8	2	14	4	6	11	18
2022/2023	193	27	28	22	30	11	27	7	16	17	0	8	0
2023/2024	75	2	22	3	3	4	22	0	0	0	2	4	13
2024/2025	146	3	3	12	5	33	1	6	1	11	12	39	20
2025/2026	371	62	11	19	38	88	16	66	15	27	29	0	0
Totale													1.137

IRIS UniCatt